The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Adelman Burt A since year 2005.
The trader's CIK number is 1226283.
At the time of this reporting, Adelman Burt A is the EVP, Development of
Biogen Idec Inc
(stock ticker symbol BIIB).
Stock purchases, sales, and option exercises reported by Adelman Burt A since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-10-15
BIIB
Biogen Idec Inc
Option Exercise
60,500
64.92
3,927,962
2007-10-15
BIIB
Biogen Idec Inc
Sale
60,500
82.00
4,961,000
2007-08-30
BIIB
Biogen Idec Inc
Option Exercise
46,000
49.03
2,255,380
2007-08-30
BIIB
Biogen Idec Inc
Sale
46,000
64.03
2,945,380
2007-08-27
BIIB
Biogen Idec Inc
Sale
8,750
63.50
555,625
2007-08-27
BIIB
Biogen Idec Inc
Option Exercise
8,750
43.50
380,625
2007-08-17
BIIB
Biogen Idec Inc
Option Exercise
28,750
45.46
1,306,975
2007-08-17
BIIB
Biogen Idec Inc
Sale
28,750
60.46
1,738,258
2007-07-25
BIIB
Biogen Idec Inc
Option Exercise
29,000
40.48
1,173,775
2007-07-26
BIIB
Biogen Idec Inc
Option Exercise
115,000
49.61
5,705,150
2007-07-25
BIIB
Biogen Idec Inc
Sale
29,000
57.98
1,681,275
2007-07-26
BIIB
Biogen Idec Inc
Sale
115,000
59.61
6,855,150
2007-07-03
BIIB
Biogen Idec Inc
Option Exercise
10,225
44.24
452,354
2007-07-03
BIIB
Biogen Idec Inc
Sale
10,225
54.24
554,604
2007-03-20
BIIB
Biogen Idec Inc
Sale
6,634
44.48
295,073
2007-02-13
BIIB
Biogen Idec Inc
Sale
11,871
49.22
584,243
2007-02-06
BIIB
Biogen Idec Inc
Option Exercise
5,467
.00
0
2006-09-19
BIIB
Biogen Idec Inc
Sale
18,348
42.76
784,624
2006-01-03
BIIB
Biogen Idec Inc
Option Exercise
103,500
29.47
3,050,145
2006-01-03
BIIB
Biogen Idec Inc
Sale
103,500
45.46
4,705,110
2005-12-28
BIIB
Biogen Idec Inc
Option Exercise
20,500
16.90
346,449
2005-12-28
BIIB
Biogen Idec Inc
Sale
20,500
44.63
914,915
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Adelman Burt A
(EVP, Development of Biogen Idec Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
